

HY-P991720 · 1 mg
MedChemExpress · Cat: HY-P991720
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/tepilukimig.htmlDescription
Tepilukimig is a bivalent humanized IgG1? monoclonal antibody inhibitor targeting TSLP-IL7R? and TSLP-CRLF2. Tepilukimig inhibits the binding of TSLP to its receptors IL7R? and CRLF2 on the cell surface, thereby completely interrupting the inflammatory signaling pathway driven by TSLP. Tepilukimig can be used for allergic and inflammatory diseases like atopic dermatitis and asthma research.







